Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Migraine
Related studies linked through entity extraction aliases.
A Randomized, Multicenter, Study for the prEvention and Acute Treatment of Migraine (REAL)
- Status
- WITHDRAWN
- Phase
- NA
Imaging the Migraine Brain Pre- and Post-Erenumab
- Status
- COMPLETED
- Phase
- PHASE4
Impact of Exercise on "Invisible" Symptoms and Quality of Life in Multiple Sclerosis Individuals
- Status
- COMPLETED
- Phase
- NA
High School Start Time and Teen Migraine Frequency
- Status
- COMPLETED
- Phase
- N/A
Study of Pediatric Migraine: The Pediatric Migraine Registry
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Salivary Inflammatory Markers in Tension Type Headache and Migraine
- Status
- UNKNOWN
- Phase
- N/A
Comparison of Therapeutic Effects of Greater Occipital Nerve Block, Topiramate, and Flunarizine on Episodic Migraine
- Status
- COMPLETED
- Phase
- NA
A Study of M207 With Intranasal Zolmitriptan in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Decision Support for Patient Migraine Management
- Status
- COMPLETED
- Phase
- NA
Trans-diagnostic Cognitive-behavioral Therapy for Treatment of Migraine
- Status
- COMPLETED
- Phase
- NA
Objectively Diagnose and Monitor Treatment of Light Sensitivity
- Status
- RECRUITING
- Phase
- NA
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
- Status
- COMPLETED
- Phase
- PHASE3
Sphenopalatine Ganglion Blocks RCT
- Status
- COMPLETED
- Phase
- PHASE4
LSFG-SKIN, Laser Speckle Flowgraphy
- Status
- TERMINATED
- Phase
- NA
CHOCOlate MeLatonin for AdolescenT MigrainE
- Status
- COMPLETED
- Phase
- PHASE2
Vagus Nerve Stimulation and Stress Reduction Training for Migraine
- Status
- COMPLETED
- Phase
- NA
Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine
- Status
- COMPLETED
- Phase
- PHASE3